Balentine LLC Medtronic PLC Transaction History

Balentine LLC

$2.54 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$69.43 - $83.43 $197,806 - $237,692	-2,849 Reduced 31.8%	6,110 $503,000
Q3 2023 Nov 13, 2023	BUY	$78.22 - $90.4 $7,196 - $8,316	92 Added 1.04%	8,959 $702,000
Q2 2023 Aug 14, 2023	SELL	$79.47 - $91.38 $230,463 - $265,002	-2,900 Reduced 24.65%	8,867 $781,000
Q1 2023 May 11, 2023	BUY	$76.72 - $87.58 $440,296 - $502,621	5,739 Added 95.21%	11,767 $948,000
Q4 2022 Jan 31, 2023	SELL	$76.18 - $87.74 $137,352 - $158,195	-1,803 Reduced 23.02%	6,028 $468,000
Q3 2022 Oct 26, 2022	BUY	$80.75 - $95.31 $38,921 - $45,939	482 Added 6.56%	7,831 $632,000
Q2 2022 Oct 26, 2022	SELL	$87.4 - $113.09 $1.15 Million - $1.48 Million	-13,106 Reduced 64.07%	7,349 $660,000
Q2 2022 Aug 15, 2022	SELL	$87.4 - $113.09 $1.15 Million - $1.48 Million	-13,106 Reduced 64.07%	7,349 $660,000
Q1 2022 Oct 26, 2022	BUY	$100.58 - $112.38 $1.32 Million - $1.47 Million	13,106 Added 178.34%	20,455 $2.27 Million
Q1 2022 May 06, 2022	BUY	$100.58 - $112.38 $1.54 Million - $1.72 Million	15,310 Added 297.57%	20,455 $2.27 Million
Q4 2021 Oct 26, 2022	SELL	$99.53 - $127.75 $249,223 - $319,886	-2,504 Reduced 34.07%	4,845 $501,000
Q4 2021 Feb 02, 2022	SELL	$99.53 - $127.75 $226,530 - $290,759	-2,276 Reduced 30.67%	5,145 $532,000
Q3 2021 Nov 15, 2021	BUY	$122.75 - $135.17 $678,439 - $747,084	5,527 Added 291.82%	7,421 $930,000
Q2 2021 Aug 16, 2021	BUY	$118.19 - $131.5 $14,773 - $16,437	125 Added 7.07%	1,894 $235,000
Q1 2021 May 10, 2021	BUY	$111.18 - $119.74 $196,677 - $211,820	1,769 New	1,769 $209,000
Q3 2020 Nov 02, 2020	SELL	$90.13 - $108.78 $82,108 - $99,098	-911 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$84.11 - $103.33 $45,587 - $56,004	542 Added 146.88%	911 $84,000
Q1 2020 May 18, 2020	SELL	$72.92 - $121.3 $35,876 - $59,679	-492 Reduced 57.14%	369 $33,000
Q4 2019 Sep 02, 2020	BUY	$104.49 - $114.54 $70,321 - $77,085	673 Added 357.98%	861 $98,000
Q3 2019 Nov 15, 2019	BUY	$98.02 - $111.18 $4,018 - $4,558	41 Added 27.89%	188 $20,000
Q2 2019 Aug 14, 2019	BUY	$84.15 - $99.38 $12,370 - $14,608	147 New	147 $14,000
Q3 2018 Nov 14, 2018	SELL	$85.91 - $99.17 $10,738 - $12,396	-125 Closed	0 $0
Q1 2018 May 16, 2018	SELL	$76.55 - $87.26 $249,935 - $284,903	-3,265 Reduced 96.31%	125 $10,000
Q4 2017 Feb 14, 2018	SELL	$76.93 - $83.5 $615 - $668	-8 Reduced 0.24%	3,390 $274,000
Q3 2017 Nov 15, 2017	BUY	$77.71 - $84.6 $264,058 - $287,470	3,398	3,398 $264,000

Others Institutions Holding MDT

# of Institutions

2,288

Shares Held

1.02B

Call Options Held

8.05M

Put Options Held

7.19M

Vanguard Group Inc Valley Forge, PA

123M
Shares

$10 Billion
0.2% of portfolio
Black Rock Inc. New York, NY

112M
Shares

$9.07 Billion
0.2% of portfolio
State Street Corp Boston, MA

60.7M
Shares

$4.92 Billion
0.23% of portfolio
Capital Research Global Investors Los Angeles, CA

32.6M
Shares

$2.64 Billion
0.63% of portfolio
Jpmorgan Chase & CO New York, NY

30M
Shares

$2.43 Billion
0.22% of portfolio

View Full List

About Medtronic plc

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $108B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

More about MDT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balentine LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balentine LLC with notifications on news.

Account